PRGSProgress Software Corporation

$46.43+3.5% 1Y
Latest close: a new 52-week highOct 23, 2026what changed →

Is the business good?

Mixed

The checks split: 7 of 9 health tests passed and earnings fully cash-backed (2.2×), but returns that lean on debt.

2 good, 1 to watch, 1 neutral
Fundamental health (F-score)7 / 9SEC EDGAR · Nov 30, 2025

High fundamental quality. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash2.23×derived · Aug 31, 2026

Operating profit is fully backed by cash. Conversion is improving vs a year ago.

Margin direction, 3 years−0.0 pts

Positive operating leverage, operating profit is growing faster than sales, so margins widen as the business scales.

Where ROE comes from4.7× leverage

Leverage-amplified, a high assets-to-equity ratio does much of the work. ROE 17% = margin × turnover × leverage.

Unless marked, from derived.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversiontop 3% of the market
Leverage (Debt/EBITDA)behind 77% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is PRGS?

Progress Software Corporation earns 8.5% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.

8.5%

Return on invested capital · cost of capital 9.0% · 0.54 points below what the capital costs: growth destroys value

Operating margin
18%

Operating margin · Software - Infrastructure median 7.5% · 12 months to Q3 2026

Cash conversion
2.23×

Cash conversion · 2.08× a year ago · operating cash flow covers the operating profit after tax

Share count, year on year
−5.1%

Share count, year on year · bought back, each share owns more of the company

Operating margin by fiscal year
YearOperating margin
FY202024%
FY202122%
FY202222%
FY202316%
FY202416%
FY202516%
Details›
Gross margin12 months to Q3 2026
82%
Operating margin12 months to Q3 2026
18%
Net margin12 months to Q3 2026
9.2%
Free cash flow margin
32%
R&D as % of revenue
20%
Revenue, trailing twelve months
$1000M
Free cash flow, trailing twelve months
$319M
Net income, trailing twelve months
$92M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
8.5%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.